Darier disease successfully treated with a topical agent containing vitamin A (retinyl palmitate), vitamin E, and urea

• Published in: Journal of dermatology 2022-08, Vol.49 (8), p.779-782
• Main Authors: Miyazaki, Akira, Taki, Tomoki, Takeichi, Takuya, Kono, Michihiro, Yagi, Hiroaki, Akiyama, Masashi
• Format: Article
• Language: English
• Subjects: Acetic acid; Adverse events; Biopsy; Darier's disease; Drug delivery; Dyskeratosis; Epidermis; Hereditary diseases; Keratinization; Keratosis; keratosis follicularis; Palmitic acid; Patients; Plaques; retinoic acid; retinoid; Retinoids; Scalp; Skin diseases; Skin lesions; tocopheryl acetate; Topical medication; Urea; Vitamin A; vitamin A analog; Vitamin E
• ISSN: 0385-2407; 1346-8138
• DOI: 10.1111/1346-8138.16395

Darier disease (DD), also called keratosis follicularis, is an autosomal dominant hereditary keratinization disorder that manifests as keratotic papules with plaques in seborrheic areas. There are no validated curative treatments for DD, with the majority of cases treated symptomatically. We report the efficacy of a topical over‐the‐counter agent which contains retinyl palmitate, vitamin E, and urea for a patient with DD. A 13‐year‐old girl had brown papules on her scalp, neck, shoulders, and axillae since entering elementary school. A skin biopsy revealed hyperkeratosis, suprabasal acantholysis, and dyskeratosis manifested as corps ronds and grains in the epidermis. Sanger sequencing found the previously reported heterozygous mutation c.1484C>T in ATP2A2. The application of an over‐the‐counter topical agent containing retinyl palmitate 2750 μg/g (5000 IU/g), tocopheryl acetate 20 mg/g, urea 200 mg/g, and monoammonium glycyrrhizinate 5 mg/g twice daily for 2 months improved the papules without serious adverse events. Oral or topical aromatic vitamin A analogs (retinoids) are often used to treat DD. However, several adverse events are associated with retinoid treatment, and many patients only undergo their intermittent use or discontinue the treatments. Retinyl palmitate is more stable and has a lower irritative profile than other retinoic acids. When applied topically, however, retinyl palmitate cannot penetrate the skin as well as retinol can. Some reports have noted that vitamin E increases the biological availability of vitamin A and that urea helps mechanical percutaneous drug delivery. Our case suggests that retinyl palmitate has a sufficient therapeutic effect when combined with vitamin E and urea. In conclusion, we propose that topical agents containing retinyl palmitate, vitamin E, and urea might have a satisfactory effect on the skin lesions of DD patients, without the serious risks of adverse events.